SCA45 Diagnosis and Treatment
For suspected SCA45 (FAT2-associated cerebellar ataxia), whole genome sequencing should be performed as first-line genetic testing after initial MRI brain imaging to exclude structural causes, with formal genetic counseling both before and after testing. 1
Diagnostic Approach
Initial Imaging
Begin with MRI head without IV contrast as the initial imaging modality for any patient presenting with chronic cerebellar ataxia 2. This is critical to:
- Detect cerebellar volume loss and parenchymal injury patterns
- Exclude non-degenerative causes (mass lesions, infarcts, structural abnormalities)
- Identify patterns suggestive of specific ataxia subtypes, though significant overlap exists
Important caveat: Conventional neuroimaging may be unremarkable in early disease, so a normal MRI does not exclude hereditary ataxia 2.
Genetic Testing Strategy
Whole genome sequencing is recommended as first-line genetic testing for unexplained ataxia, with particular emphasis on detecting repeat expansions 1. This approach is superior to sequential single-gene testing given the complex genetic heterogeneity of spinocerebellar ataxias.
For SCA45 specifically:
- Look for variants in the FAT2 gene (cadherin family member)
- SCA45 was originally described as late-onset (>40 years) pure cerebellar syndrome 3
- However, early-onset phenotypes have now been reported (as young as 22 years), presenting with pan-cerebellar syndrome 3
- Novel missense variants continue to be identified 3
Essential Pre-Test Counseling Components
Formal genetic counseling must occur before testing 1, addressing:
- Inheritance patterns and implications for family members
- Potential for cascade testing of at-risk relatives
- Insurance considerations
- Psychological impact of results
- Possibility of variants of uncertain significance
Clinical Features to Document
The diagnosis relies on combining history, thorough neurologic examination, imaging, and confirmatory genetic testing 2. Specifically document:
- Age of onset (SCA45 can present earlier than initially recognized)
- Pattern of ataxia (truncal vs appendicular)
- Associated features (oculomotor abnormalities, dysarthria, cognitive changes)
- Family history pattern (autosomal dominant inheritance expected)
- Rate of progression
Treatment Approach
There are currently no FDA or EMA-approved disease-modifying therapies for any spinocerebellar ataxia, including SCA45 4. Management is entirely symptomatic and supportive.
Symptomatic Management Framework
Pharmacological interventions (limited evidence):
- Target specific symptoms as they emerge (dysarthria, sleep disturbances, depression)
- Manage cerebellar cognitive-affective syndrome when present
- Address comorbid depression and anxiety
Non-pharmacological interventions (primary focus):
- Physical therapy to maintain functional independence
- Occupational therapy for activities of daily living
- Speech therapy for dysarthria
- Balance training programs
- Assistive devices as disability progresses
Multidisciplinary Referrals
Early ophthalmology referral is particularly important 5, as:
- Certain ocular findings can help narrow differential diagnosis among SCA subtypes
- Macular and optic nerve involvement patterns differ by SCA type
- Early detection may guide more targeted genetic testing
Genetic counseling referral for:
- Post-test result interpretation 1
- Cascade testing coordination for at-risk family members
- Reproductive counseling if desired
Monitoring and Future Considerations
- Regular follow-up to assess progression and adjust supportive care
- Consider enrollment in clinical trials investigating gene and cell therapies currently under development 4
- Transition to precision medicine approaches and early intervention at pre-ataxic stages represent future directions 4
Critical Pitfalls to Avoid
Do not delay genetic testing - Patients often experience years of diagnostic delay across multiple consultations 5. Expedite comprehensive genetic evaluation once hereditary ataxia is suspected.
Do not skip formal genetic counseling - Testing without proper counseling can lead to inadequate understanding of results and family implications 1.
Do not assume typical age of onset - SCA45 can present much earlier than the originally described late-onset pattern 3.
Do not rely solely on imaging - Normal MRI does not exclude diagnosis, particularly in early disease 2.